Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA

Area of Science:

• Molecular Biology
• DNA Repair Mechanisms
• Structural Biology

Background:

• The nucleotide excision repair (NER) pathway is crucial for correcting DNA damage from various sources.
• NER functions through the ordered assembly of protein complexes at damaged DNA sites.
• Protein-protein and protein-DNA interactions are key to NER's efficiency.

Purpose of the Study:

• To investigate the essential protein-protein interaction between XPA (xeroderma pigmentosum complementation group A) protein and ERCC1 (excision repair cross-complementation group 1) within the NER pathway.
• To characterize the structural basis of XPA binding to ERCC1 and its functional implications.
• To explore the potential for developing therapeutic agents targeting NER.

Main Methods:

• Determined the crystal structure of the ERCC1 protein in complex with a peptide derived from XPA.
• Assessed the binding affinity between the XPA peptide and ERCC1 using biophysical techniques.
• Evaluated the inhibitory effect of the XPA peptide on NER activity in a cell-free system, specifically its impact on cisplatin adduct removal.

Main Results:

• A small region of XPA binds to ERCC1, forming a stable complex with submicromolar affinity.
• The XPA peptide acts as a potent inhibitor of NER in vitro, blocking DNA repair.
• Structural analysis revealed a druggable binding interface on ERCC1 for the XPA peptide.

Conclusions:

• The interaction between XPA and ERCC1 is critical for NER pathway function.
• The identified XPA-ERCC1 binding interface can be targeted for developing small molecule inhibitors.
• These inhibitors could potentially modulate NER activity in vivo, offering therapeutic avenues.